Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Inventory (2020 - 2025)

NeuroPace has reported Inventory over the past 6 years, most recently at $16.9 million for Q4 2025.

  • Quarterly results put Inventory at $16.9 million for Q4 2025, up 26.27% from a year ago — trailing twelve months through Dec 2025 was $16.9 million (up 26.27% YoY), and the annual figure for FY2025 was $16.9 million, up 26.27%.
  • Inventory for Q4 2025 was $16.9 million at NeuroPace, down from $18.1 million in the prior quarter.
  • Over the last five years, Inventory for NPCE hit a ceiling of $18.1 million in Q3 2025 and a floor of $7.0 million in Q2 2021.
  • Median Inventory over the past 5 years was $10.4 million (2023), compared with a mean of $10.9 million.
  • Biggest five-year swings in Inventory: increased 6.2% in 2024 and later surged 50.07% in 2025.
  • NeuroPace's Inventory stood at $7.8 million in 2021, then increased by 24.16% to $9.7 million in 2022, then increased by 15.47% to $11.2 million in 2023, then rose by 19.32% to $13.4 million in 2024, then rose by 26.27% to $16.9 million in 2025.
  • The last three reported values for Inventory were $16.9 million (Q4 2025), $18.1 million (Q3 2025), and $16.3 million (Q2 2025) per Business Quant data.